Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Learn which low fee index funds beat the market in 2024 and how they can fit into a retirement strategy. This guide highlights top performers and practical steps for investors.
28,527 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
When a CEO sells a sizable stake, investors ask: what does it mean for the stock? This piece unpacks Universal Techni...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...
Investors are weighing memory constraints and AI demand against Nvidia’s growth potential beyond GPUs as the company ...
Investors want a clear compass for Alphabet stock in the next five years. This article breaks down the growth drivers...
Vitalik Buterin has resumed selling ETH, logging new multi-million transfers as ether struggles to stay above the $2,...
The National Association of Realtors unveils a loan-focused podcast series designed to translate financing trends int...
Jim Cramer’s take on Power Solutions International’s sharp drop spotlights a potential entry point for data center-re...
Tesla's stock has traded with unusual calm as the company advances robotaxis and semiconductor initiatives. Early pil...
A notorious short-seller unloaded sofi this week with sweeping accusations, but the stock shrugged off most of the blow.
The U.S. labor market produced a modest April gain, with the economy added 115,000 jobs and unemployment steady at 4....